Key result
Intravenous r-hirudin provided a long-lasting anticoagulant effect in nephrectomized dogs during hemodialysis, preventing pressure increases and reducing drops in fibrinogen and platelets.
Why the study?
Does intravenous r-hirudin prevent thrombus formation in Beagle dogs undergoing experimental hemodialysis?
Does intravenous r-hirudin prevent thrombus formation in Beagle dogs undergoing experimental hemodialysis?
Recombinant hirudin at 0.5 mg/kg provides effective anticoagulation without bleeding complications in a canine model of experimental hemodialysis.
Answers are grounded in this paper and cite their sources.
Supports r-hirudin anticoagulation in experimental canine hemodialysis; leaves open human translation pending clinical trials.
After genetically engineered recombinant DNA desulfatohirudin (r-hirudin) had been investigated as to its pharmacokinetic behavior and blood level course in nephrectomized dogs, the compound was studied for its capability to prevent thrombus formation in the extracorporeal circulation. Beagle dogs underwent bilateral functional nephrectomy followed by experimental hemodialysis. r-Hirudin content in blood, fibrinogen level as well as platelet count were determined before and during the dialysis. Furthermore, the blood loss during the experiment was measured as well as the mean arterial pressure and the pressure in the blood line system. Intravenous administration of the thrombin inhibitor resulted in initial distribution in the extracellular space (distribution phase 90 min) followed by retarded decrease of the r-hirudin blood level (t1/2 beta approximately 6-8 h) which is due to the missing renal excretion of the inhibitor. This caused a long-lasting, dose-dependent anticoagulant effect, which is not only characterized by the prevention of increasing pressure before the capillary dialyzer but also by the reduced drop in fibrinogen and platelets during hemodialysis. The required dose of r-hirudin (0.5 mg/kg) is within a range where bleeding complications will not occur yet.
No takes yet. Share an insight, caveat, or question.
Markwárdt et al. (2009) studied Experimental hemodialysis. r-hirudin was evaluated on Prevention of thrombus formation in extracorporeal circulation. Intravenous r-hirudin provided a long-lasting anticoagulant effect in nephrectomized dogs during hemodialysis, preventing pressure increases and reducing drops in fibrinogen and platelets.
Synapse has enriched 10 related papers. Consider them for comparative context: